Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Medchemcomm
|
August 16, 2018
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy <i>via</i> screening of a natural product repository
Prashant Joshi, Vinay R Sonawane, Ibidapo S Williams, et al.
British Journal of Clinical Pharmacology
|
May 1, 1992
A pharmacokinetic and pharmacodynamic comparison of plain and enteric-coated prednisolone tablets
C G Adair, O McCallion, J C McElnay, et al.
Journal of Animal Science
|
May 26, 1999
Effects of bovine somatotropin and ruminally undegraded protein on feed intake, live weight gain, and mohair production by yearling Angora wethers
J J Davis, T Sahlu, R Puchala, et al.
Organic & Biomolecular Chemistry
|
October 8, 2016
Biphenyl urea derivatives as selective CYP1B1 inhibitors
Mohd Usman Mohd Siddique, Glen J P McCann, Vinay Sonawane, et al.
European Journal of Medicinal Chemistry
|
March 6, 2017
Quinazoline derivatives as selective CYP1B1 inhibitors
Mohd Usman Mohd Siddique, Glen J P McCann, Vinay R Sonawane, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2017
(E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent
Neill J Horley, Kenneth J M Beresford, Supriya Kaduskar, et al.
European Journal of Medicinal Chemistry
|
December 7, 2025
Exploring novel aromatase cytochrome P450-binding ligands: Molecular docking and QSAR study of phorbol esters as aromatase inhibitors
Abdellah Ezzanad, Felipe Escobar-Montaño, Jesus Sánchez-Márquez, et al.
European Journal of Medicinal Chemistry
|
February 22, 2017
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines
Neill J Horley, Kenneth J M Beresford, Tarun Chawla, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Medchemcomm
|
August 16, 2018
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy <i>via</i> screening of a natural product repository
Prashant Joshi, Vinay R Sonawane, Ibidapo S Williams, et al.
British Journal of Clinical Pharmacology
|
May 1, 1992
A pharmacokinetic and pharmacodynamic comparison of plain and enteric-coated prednisolone tablets
C G Adair, O McCallion, J C McElnay, et al.
Journal of Animal Science
|
May 26, 1999
Effects of bovine somatotropin and ruminally undegraded protein on feed intake, live weight gain, and mohair production by yearling Angora wethers
J J Davis, T Sahlu, R Puchala, et al.
Organic & Biomolecular Chemistry
|
October 8, 2016
Biphenyl urea derivatives as selective CYP1B1 inhibitors
Mohd Usman Mohd Siddique, Glen J P McCann, Vinay Sonawane, et al.
European Journal of Medicinal Chemistry
|
March 6, 2017
Quinazoline derivatives as selective CYP1B1 inhibitors
Mohd Usman Mohd Siddique, Glen J P McCann, Vinay R Sonawane, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2017
(E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent
Neill J Horley, Kenneth J M Beresford, Supriya Kaduskar, et al.
European Journal of Medicinal Chemistry
|
December 7, 2025
Exploring novel aromatase cytochrome P450-binding ligands: Molecular docking and QSAR study of phorbol esters as aromatase inhibitors
Abdellah Ezzanad, Felipe Escobar-Montaño, Jesus Sánchez-Márquez, et al.
European Journal of Medicinal Chemistry
|
February 22, 2017
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines
Neill J Horley, Kenneth J M Beresford, Tarun Chawla, et al.
Page
of 6